CARGO Therapeutics

CARGO Therapeutics is a biopharmaceutical company based in San Carlos, California, focused on developing next-generation transformational car t-cell therapies to outsmart cancer and deliver more cures for patients. The company's pipeline includes two lead candidates, firi-cel (CRG-022) and CRG-023, and is actively participating in investor conferences and providing business updates.